Towards effective data sharing in ophthalmology: data standardization and data privacy

W Halfpenny, SL Baxter - Current opinion in ophthalmology, 2022 - journals.lww.com
Information sharing is fundamental to both research and care delivery, and standardization/
privacy are key constituent considerations. Therefore, widespread engagement with, and …

Blueprint for harmonising unstandardised disease registries to allow federated data analysis: prepare for the future

JA Kroes, AT Bansal, E Berret, N Christian… - ERJ open …, 2022 - Eur Respiratory Soc
Real-world evidence from multinational disease registries is becoming increasingly
important not only for confirming the results of randomised controlled trials, but also for …

Risk of post‐injection endophthalmitis peaks within the first three injections of anti‐vascular endothelial growth factor therapy: A nationwide registry‐based study

BS Thinggaard, F Pedersen, R Kawasaki… - Acta …, 2024 - Wiley Online Library
Purpose To report the incidence of post‐injection endophthalmitis (PIE) and the cumulative
risk associated with repeated injections of intravitreal anti‐vascular endothelial growth factor …

Postintravitreal Injection Endophthalmitis: Incidence, Characteristics, Management, and Outcome

B Davidov, A Ohayon, O Trivizki… - Journal of …, 2023 - Wiley Online Library
Purpose. Postintravitreal injection (IVI) endophthalmitis is a rare but devastating
complication. Herein, we report the incidence, and clinical and microbiological …

[HTML][HTML] Real-World Treatment Intensity and Patterns in Patients With Myopic Choroidal Neovascularization: Common Data Model in Ophthalmology

MH Bui, DY Lee, SJ Park… - Journal of Korean Medical …, 2023 - synapse.koreamed.org
Background A paucity of data addressing real-world treatment of myopic choroidal
neovascularization (mCNV) in the era of anti-vascular endothelial growth factor (VEGF) …

Real-world treatment intensities and pathways of macular edema following retinal vein occlusion in Korea from Common Data Model in ophthalmology

Y Mun, CH Park, DY Lee, TM Kim, KW Jin, S Kim… - Scientific Reports, 2022 - nature.com
Despite many studies, optimal treatment sequences or intervals are still questionable in
retinal vein occlusion (RVO) macular edema. The aim of this study was to examine the real …

Drugs used in ocular treatment

RS Duszak, ER Carr, RK Acharya… - Side Effects of Drugs …, 2022 - Elsevier
The side effects of drugs annuals form a series of volumes in which the adverse effects of
drugs and adverse reactions to them are surveyed. The series supplements the contents of …

Efficacy of Injection Interval Shortening in Neovascular Age-related Macular Degeneration with Limited Response to Bimonthly Aflibercept

MC Kim, JH Kim - Journal of the Korean Ophthalmological Society, 2023 - jkos.org
Purpose: To investigate the effectiveness of shortening the injection interval to< 2 months in
neovascular age-related macular degeneration (AMD) with limited response to bimonthly …

Real-world studies of biological treatment in severe asthma: population-based registries, prediction of response and patient-tailored outcomes

H Kroes - 2023 - research.rug.nl
This thesis focuses on real-world studies of biological treatment in severe asthma. We
studied the real-world effectiveness of the expensive biologics, adding to the knowledge …

[HTML][HTML] Short-term Anatomical Outcomes of Switching from Bevacizumab to the Ranibizumab Biosimilar CKD-701 in Neovascular Age-related Macular Degeneration

YS Yoon, JH Kim - Journal of Retina, 2024 - e-retina.or.kr
Purpose: To evaluate and report the short-term anatomical effects of switching from
bevacizumab to the ranibizumab biosimilar CKD-701 in patients undergoing treatment for …